乌鸦传媒

USPSTF says new findings were consistent with those of previous review

Pregnant people and those who are immunocompromised most at risk, agency warns

Longer-acting crovalimab designed for more sustained effect and less treatment burden

Those with higher lead levels in household drinking water more likely to need maximum ESA dosing

Indication for HIF-PH inhibitor vadadustat limited to patients already on dialysis

Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment

Lifetime reduction in acute pain episodes should offset high upfront costs of the therapy

Results suggest a "paradigm shift" in the treatment of anemia for these patients

What effects might emerging therapies have on real-world survival?

Trial confirms higher rate of hypophosphatemia with ferric carboxymaltose

In small study, mitapivat increased hemoglobin in 80% of non-transfusion-dependent patients

COVID-19 severity strongly linked with sickle cell anemia as well

Study finds risk was low, but unequal across different products

HIF-PHI daprodustat increased hemoglobin without hurting heart